Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

Vitamin C (ascorbic acid)

Also known as: vitamin C, ascorbic acid, L-ascorbic acid, LAA

Topical vitamin C includes L-ascorbic acid and several distinct derivatives used for antioxidant, pigmentation and photoageing aims. L-ascorbic acid is biologically established but difficult to formulate; clinical outcomes depend on the exact molecule, vehicle, stability and finished-product evidence.

Evidence status

Moderate

Established antioxidant and collagen-cofactor biology, with promising but small and heterogeneous clinical evidence for pigmentation and photoageing. Several of the most-quoted formulation rules come from pig-skin studies authored by the founder of the brand that sells the tested formula.

What topical vitamin C is, and the forms available#

Topical vitamin C covers L-ascorbic acid — the biologically active form — and a family of derivatives developed largely to solve its central formulation problem: L-ascorbic acid is unstable, awkward to work with and oxidises readily.

L-ascorbic acid, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbyl-6-palmitate, tetrahexyldecyl ascorbate and ascorbyl glucoside are different molecules. They differ in stability, in whether they penetrate, in whether they convert to ascorbic acid once they do, and in how much finished-product evidence exists for each.[3, 8]

The evidence therefore belongs to particular molecules and particular finished products rather than to the category, and a study of one says little about the others. The biology of ascorbate is well established; the difficulty in this category is everything between the biology and the bottle.

Use of vitamin C in aesthetic practice#

Topical vitamin C is a cosmetic rather than a prescribed product, and the whole family — L-ascorbic acid and derivatives alike — is yours to recommend, retail and apply.

What that places in an aesthetic practitioner’s hands is a product decision rather than an ingredient one. “Contains vitamin C” on a label names a family; the molecule, its concentration, the vehicle and the packaging decide what reaches the skin. Where a supplier makes a claim for an ingredient, the corresponding question is what evidence exists for the finished product, since the two are routinely conflated.

In a daily routine it is conventionally used on the morning side, as antioxidant support alongside photoprotection.

Contraindications and cautions#

Sensitivity to acidic formulations

L-ascorbic acid systems are formulated at low pH, and stinging on application is the usual tolerance limit — it is the effect the derivatives are marketed as avoiding. Tolerance decides the outcome here more often than potency does, because a well-formulated derivative in continued use is worth more in practice than an acidic serum abandoned early.

Reactions attributed to combinations

Where a specific pairing stings a specific client, the operative variables are tolerance and formulation rather than a chemical interaction between two actives.

Clinical uses and the evidence behind them#

Photoageing and wrinkle appearance

What exists at product level is narrow and specific. A six-month double-blind randomised paired trial compared a 5% cream against its own excipient on photoaged low-neck and arm skin, and investigator and self-assessment both favoured the active side. One named branded serum improved profilometry roughness and shadows in nineteen evaluable people.[5, 6]

Both are results for a formulation, in a small and selected group. They support recommending a particular product on its own evidence, and they do not carry across to every serum in the category.

The ceiling above them is the systematic review of topical vitamin C for wrinkles, which gathered 139 volunteers across seven publications and attributed no wrinkle effect to vitamin C on its own.[1, 2] That is a failure of attribution rather than a demonstration that nothing happens, and it is equally not evidence of benefit.

Pigmentation and melasma

The evidence here is promising, small and heterogeneous, across studies whose formulations and indications vary.[1, 2] It supports offering a product as part of a pigmentation routine. It does not support promising a client clearance.

Photoprotective support

Vitamin C supplements photoprotection rather than providing it. An SPF number is not a property of an ingredient: it is generated by a standardised test method performed on a finished product, and no vitamin C formulation in the sources reviewed here was tested for, or assigned, one.[no source found]

The antioxidant action addresses a different part of the problem — free radicals generated by radiation that has already reached the skin — rather than absorbing or reflecting the radiation itself. The sunscreen a client needs is unchanged by the presence of a vitamin C product, and describing one as extra SPF has nothing behind it.

One antioxidant solution has been tested on human skin for this purpose, and the protection it reported belongs to the specific formulation tested rather than to vitamin C in general.[4, 10]

Selecting a vitamin C product#

The selection is made on the molecule, the formulation, the packaging and what the client will tolerate. An elegantly stabilised 10% in opaque, air-restrictive packaging will outperform an oxidised 20% in a dropper bottle, which makes the percentage on the front of the bottle the least informative number on it.

L-ascorbic acid and the derivatives

Derivatives are sold on tolerability and stability — gentler, less prone to oxidation, no low-pH sting. Those are real formulation advantages.

Whether they deliver ascorbic acid to the skin is a separate question, and it has been tested directly. In the pig-skin penetration study, magnesium ascorbyl phosphate, ascorbyl-6-palmitate and dehydroascorbic acid did not increase skin levels of L-ascorbic acid.[3]

That is one study, in one model, from 2001, and formulation science has moved since. It is nonetheless a directly tested result rather than an assumption, and it leaves the position as follows: L-ascorbic acid carries the direct evidence and the formulation problems, derivatives carry the elegance and much weaker delivery evidence, and a supplier claiming equivalence is describing something that would need finished-product evidence to support.

Concentration and pH

The two figures in circulation — below pH 3.5, and no benefit above 20%— come from a percutaneous absorption study in which penetration rose as pH fell below 3.5 and as concentration rose towards 20%, above which it fell away. The study was performed on pig skin, and describes one L-ascorbic acid system.[3]

The consequence for selection is that concentration is not potency. A higher number describes how much is in the bottle rather than how much reaches the skin or how long it survives there, and formulation and packaging move that further than the percentage does.

The vitamin C, E and ferulic acid solution

The most-copied formulation in professional skincare is 15% L-ascorbic acid, 1% alpha-tocopherol and 0.5% ferulic acid, in which ferulic acid stabilises the vitamin C and E combination.[4, 10]

The evidence attaches to that composition at those concentrations. It is well-reasoned chemistry with real supporting work, and an ingredient list containing the same three names is a different product until its own evidence says otherwise.

Stability, storage and discolouration

L-ascorbic acid oxidises, and a serum turns yellow, then orange, then brown. No validated colour chart exists in any source reviewed here to say at which shade a product should be discarded.[no source found]

What can be stated is that darkening indicates oxidation, oxidation means less active L-ascorbic acid, and a heavily discoloured product is likely to be doing less than it was. Smaller volumes, opaque air-restrictive packaging and sensible storage follow from that; a colour threshold does not.

Use alongside niacinamide

The rule against layering vitamin C with niacinamide traces to a 1968 analytical-chemistry paper that ran polarography on the two molecules in water and observed a coloured complex. There was no skin, no finished product, no efficacy endpoint and no harm endpoint, and the concentrations used were roughly ten times below typical cosmetic levels rather than above them.[9]

The folklore also fuses two laboratory questions: mid-century solution studies of how nicotinamide and ascorbic acid associate with one another, and a separate literature on niacinamide hydrolysing to niacin under heat, work that did not involve vitamin C at all. Neither examined a modern finished cosmetic on human skin.

There is no good evidence that layering modern finished products of each is either ineffective or harmful.

Adverse effects and their management#

Stinging and tolerance

Stinging or transient smarting on application is the effect most often associated with acidic L-ascorbic acid systems, and it is the one the derivatives are formulated and marketed to avoid. Where it persists it determines adherence rather than efficacy, and a product that is not used produces nothing.

Reducing, stopping and referring

Where an acidic system is not tolerated, the alternatives are a better-formulated product at a similar concentration or a derivative with weaker delivery evidence.[3] The trade-off is between the strength of the delivery evidence and the likelihood of continued use.

None of the sources reviewed here sets a threshold at which a vitamin C product is stopped rather than changed, which leaves that a tolerance and product decision. What warrants referral is the presentation rather than the product.

Referral and scope boundaries#

A vitamin C product is a cosmetic recommendation, and it sits outside the diagnosis of the conditions it is most often bought for. The evidence in pigmentation and melasma is small and heterogeneous, which makes it neither a cure nor a substitute for a diagnosis.[1, 2]

Where a pigmentary presentation has not been assessed, the assessment is the referral and the product decision follows it. Antioxidant support, photoprotection and adherence remain within remit alongside any medical management, and require no prescription.

Mechanism of action#

Ascorbate has two roles worth knowing. It is an antioxidant, and it is an enzymatic cofactor in collagen hydroxylation — the step that lets collagen form a stable triple helix.[8]

The cofactor role is why vitamin C and collagen are bound together throughout the category’s marketing. It is real biochemistry, and it is a mechanism rather than an outcome.

Commonly misstated claims#

Four statements circulate widely in the trade. Each is set out below with what the primary literature was found to support. A thread runs through several of them: much of the foundational work in this category was authored by or with the founder of the brand that commercialised the formulation being tested, and every such interest is declared on the source in the reference list below.

“Vitamin C has to be below pH 3.5, and 20% is the ceiling.”

Both figures come from a single percutaneous absorption study whose Methods state plainly that L-ascorbic acid and its derivatives “were applied to pig skin”.[3] Pig skin is a reasonable model for percutaneous absorption and the work is frequently cited for good reason, but a practitioner told that “the science says below pH 3.5” will reasonably assume the science was done on human skin. The paper also carries a declared commercial interest: the lead author was a consultant to SkinCeuticals and a co-author was president of PhytoCeuticals.

Supported statement: in a pig-skin model, penetration of one L-ascorbic acid system rose as pH fell below 3.5 and as concentration rose towards 20%. It is a penetration finding in a non-human model, for one formulation system.

“Any serum with C, E and ferulic acid doubles photoprotection.”

The doubling figure comes from a study in pig skin, with three animals, whose senior author, Sheldon Pinnell, founded SkinCeuticals and held the patent behind the tested formulation — and the figure went on to become that brand’s headline marketing claim.[4, 10] The later human study of the same solution reported protection against ultraviolet damage in a relatively small number of patients, and is where the 0.5% ferulic acid figure is actually stated.

Supported statement: ferulic acid stabilised one vitamin C and E solution and roughly doubled its photoprotection in a pig-skin model of three animals; the human evidence is for that composition, in a small group.

“Vitamin C improves wrinkles by 73.7%.”

The figure comes from a three-month randomised, double-blind, vehicle-controlled split-face study of one named branded serum in nineteen evaluable participants aged 36 to 72, all Fitzpatrick I to III, measuring optical-profilometry roughness and shadows.[5, 6] Nineteen people, three phototypes, one formulation.

Supported statement: one branded serum improved profilometry roughness and shadows in nineteen evaluable people with Fitzpatrick I to III skin.

“Vitamin C builds collagen.”

Ascorbate is a required enzymatic cofactor in collagen hydroxylation, which is where the claim comes from and is not in dispute.[8]Occupying a required step in a pathway is a different statement from producing a visible result, and the human evidence that would test the second — 139 volunteers across seven wrinkle publications — was confounded in every study.[1, 2]

Supported statement: vitamin C is required for collagen synthesis and topical products support that pathway; no study has cleanly attributed a collagen or wrinkle outcome to topical vitamin C by itself.

Areas of remaining uncertainty#

  • Whether the pig-skin penetration findings translate quantitatively to human skin. Until they are reproduced there, pH and percentage are formulation conventions rather than thresholds a product passes or fails.
  • Whether any derivative reliably raises ascorbic acid in human skin to a meaningful level. That leaves tolerance and finished-product evidence as the basis for choosing one.
  • How much of the C, E and ferulic acid result is ferulic acid stabilisation and how much is the two vitamins themselves. The result therefore stays attached to the composition that was tested.
  • At what point oxidation makes a product clinically useless. Until that is measured, discolouration is a potency signal, and packaging and volume are the variables worth controlling.
  • Whether topical vitamin C produces any durable collagen change in human skin, as opposed to occupying a required step in the pathway. The honest client-facing statement stays at support rather than construction.

Frequently asked questions#

Can vitamin C be used with retinoids?

Yes. The traditional morning-vitamin-C, night-retinoid split reflects photoprotection logic and tolerance rather than a demonstrated chemical incompatibility.

Should a serum be discarded once it discolours?

Darkening means oxidation, and an oxidised product is doing less than it was. No validated colour threshold exists in the literature reviewed here, which makes discolouration a potency signal rather than a safety rule.[no source found]

How long before a client sees a result?

Months. The two product-level trials ran three and six months, and the changes they recorded were modest, which makes early expectation-setting more useful than later explanation.[5, 6]

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. Correia G, Magina S. Efficacy of topical vitamin C in melasma and photoaging: A systematic review. Journal of Cosmetic Dermatology. 2023;22(7):1938–1945. doi:10.1111/jocd.15748.Tier 1Supports: The pigmentation and photoageing evidence base. NOTE: full text paywalled; cited at abstract level only.
  2. Sanabria B, Berger LE, Mohd H, et al. Clinical Efficacy of Topical Vitamin C on the Appearance of Wrinkles: A Systematic Literature Review. Journal of Drugs in Dermatology. 2023;22(9):898–904. doi:10.36849/JDD.7332.Tier 1Supports: 139 volunteers across 7 publications. Every one of the seven wrinkle studies was confounded — by combination formulas or concurrent procedures — so no wrinkle effect can be attributed to vitamin C alone. This is an attribution-failure finding, not evidence of benefit.
  3. Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery. 2001;27(2):137–142.Animal studyTier 3Supports: PIG SKIN. Penetration rose as pH fell below 3.5 and as concentration rose to 20%, above which it fell. Also directly tested three derivatives: magnesium ascorbyl phosphate, ascorbyl-6-palmitate and dehydroascorbic acid 'did not increase skin levels of L-ascorbic acid'.Funding / interest: Lead author was a consultant to SkinCeuticals; a co-author was president of PhytoCeuticals.
  4. Lin FH, Lin JY, Gupta RD, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. Journal of Investigative Dermatology. 2005;125(4):826–832.Animal studyTier 3Supports: PIG SKIN, n=3. Ferulic acid stabilised a vitamin C and E solution and roughly doubled its photoprotection in that model.Funding / interest: Senior author Sheldon Pinnell founded SkinCeuticals and held the patent behind the tested formulation, whose photoprotection figure is that brand's headline marketing claim.
  5. Humbert PG, Haftek M, Creidi P, et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Experimental Dermatology. 2003;12(3):237–244.Tier 2Supports: A six-month double-blind randomised paired trial in healthy female volunteers, comparing a 5% vitamin C cream against its own excipient on photoaged low-neck and arm skin. Investigator and self-assessment both favoured the active side, with ultrastructural changes reported.
  6. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Archives of Otolaryngology–Head & Neck Surgery. 1999;125(10):1091–1098.Tier 2Supports: A three-month randomised, double-blind, vehicle-controlled split-face study of a NAMED BRANDED PRODUCT — Cellex-C high-potency serum, Cellex-C International, Toronto — with three drops (0.5 mL) applied daily to each side of the face. NINETEEN EVALUABLE participants, aged 36 to 72, Fitzpatrick skin types I, II and III. Results: 73.7% improvement in Ra and shadows on optical profilometry, 84.2% on patient questionnaires and 57.9% on photographic assessment. SCOPE LIMIT: one named formulation, nineteen people, three phototypes. It is not evidence about topical vitamin C as a category.
  7. Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. Journal of Clinical and Aesthetic Dermatology. 2017;10(7):14–17.Tier 4Supports: Ascorbate's antioxidant activity and its role as an enzymatic cofactor in collagen hydroxylation. Also restates the pH-below-3.5 and 10–20% formulation conventions.
  8. Okazaki Y, Otsuki T, Miyasaka K, Nabikawa T. The behaviors of nicotinamide–ascorbic acid complex. Polarographic studies of charge-transfer complexes. Bunseki Kagaku. 1968;17(10):1228–1232.In vitroTier 3Supports: Polarography in aqueous solution at 0.05 M each — roughly 0.9% ascorbic acid and 0.6% niacinamide, BELOW cosmetic use levels. No skin, no finished product, no efficacy or harm endpoint.
  9. Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. Journal of the American Academy of Dermatology. 2008;59(3):418–425. doi:10.1016/j.jaad.2008.05.004.Tier 2Supports: HUMAN skin. States the tested composition explicitly: 15% L-ascorbic acid, 1% alpha-tocopherol and 0.5% ferulic acid. The authors note the number of patients evaluated was relatively small.Funding / interest: Senior author Sheldon Pinnell founded SkinCeuticals and held the patent behind the tested formulation.

Continue learning with MSTA#

Skinipedia is written by the educators at MSTA, the medic-led skincare training academy in Liverpool.